Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
European Heart Journal
Published October 5, 2026
Deep vein thrombosis exacerbated by syndecan-4 shedding and piezo1-dependent endothelial-mesenchy...
October 5, 2026
Medspoke
Medspoke
European Heart Journal
Published October 5, 2026
00:00
--:--
Semaglutide, independent of weight loss, attenuates cardiac and hepatic remodelling in experiment...
October 5, 2026
Share
Semaglutide, independent of weight loss, attenuates cardiac and hepatic remodelling in experimental heart failure with preserved ejection fraction.
https://www.medspoke.co/channel_journal?id=678&tap_id=15046
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
European Heart Journal
Published October 5, 2026
Congenital heart disease in adults: evolving health systems and lifelong outcomes.
October 5, 2026
Why are you reporting this TALK?